US FDA Grants XVIVO Approval to Include DCD Hearts in IDE Clinical Trial

XVIVO Perfusion AB The US Food & Drug Administration has approved XVIVO’s Investigational Device Exemption supplement for its heart preservation clinical trial to now include Donation after Circulatory Death hearts.